A Terms of Repayment for Unsecured Borrowings:
a Borrowings from Related Parties:
i Borrowings of ' 5,250 Million from one of the subsidiary companies will be repaid within 3 years and ' 33,070 Million will be repaid within 5 years from the date of first disbursement. Interest on loan is payable on half yearly basis. The outstanding amount as at March 31, 2026 is ' 38,320 Million [as at March 31, 2025: 41,118].
ii Borrowings of ' 400 Million from one of the subsidiary companies will be repaid within 5 years from the date of first disbursement. Interest on loan is payable on half yearly basis. The outstanding amount as at March 31, 2026 is ' 400 Million [as at March 31, 2025: 1,000].
iii Borrowings of ' 8,859 Million from one of the subsidiary companies will be repaid within 5 years from the date of first disbursement. Interest on loan is payable on half yearly basis. The outstanding amount as at March 31, 2026 is ' 8,859 Million [as at March 31, 2025: 11,074].
The interest rates on the above borrowings are in the range of Treasury Bill/ G Sec plus a margin.
Defined benefit plan and long term employment benefit
A General description:
Leave wages [Long term employment benefit]:
The leave encashment scheme is administered through Life Insurance Corporation of India's Employees' Group Leave Encashment cum Life Assurance [Cash Accumulation] Scheme. The employees of the company are entitled to leave as per the leave policy of the company. The liability on account of accumulated leave as on last day of the accounting year is recognised [net of the fair value of plan assets as at the balance sheet date] at present value of the defined obligation at the balance sheet date based on the actuarial valuation carried out by an independent actuary using projected unit credit method.
Gratuity [Defined benefit plan]:
The Company has a defined benefit gratuity plan. Every employee who has completed continuous services of five years or more gets a gratuity on death or resignation or retirement at 15 days salary [last drawn salary] for each completed year of service. The scheme is funded with an insurance company in the form of a qualifying insurance policy.
The plans typically expose the Company to actuarial risks such as: investment risk, interest rate risk, longevity risk and salary increment risk.
Investment risk:
The present value of the defined benefit plan liability is calculated using a discount rate determined by reference to the market yields on government bonds denominated in Indian Rupees. If the actual return on plan asset is below this rate, it will create a plan deficit. However, the risk is partially mitigated by investment in LIC managed fund.
Interest risk:
A decrease in the bond interest rate will increase the plan liability; however, this will be partially offset by an increase in the return on the plan's debt investments.
Longevity risk:
The present value of the defined benefit plan liability is calculated by reference to the best estimate of the mortality of plan participants both during and after their employment. An increase in the life expectancy of the plan participants will increase the plan's liability.
Salary risk:
The present value of the defined benefit plan liability is calculated by reference to the future salaries of plan participants. As such, an increase in the salary of the plan participants will increase the plan's liability.
B The Net Deferred Tax reversal of ' 656 Million [Previous Year charged of ' 873 Million] has been recognised in the Statement of Profit and Loss.
C The Company offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same tax authority.
D The Company has long term capital losses of ' 2,755 [as at March 31, 2025: 2,821] Million which are available for offset for eight years against future long term capital gains of the Company. These losses will expire in March 2032.
E For the financial year ended March 31, 2026, the Company has computed the provision for income tax as per the option permitted under section 115BAA of the Income Tax Act, 1961. Accordingly, the Company has recognised provision for income tax for the year ended March 31, 2026 and re-measured its deferred tax assets and liabilities basis the rate prescribed in the said section. Hence, the tax expense for the year ended March 31, 2026 are not comparable [Refer Note-38].
[*] Working Capital Loans which are repayable on demand, are secured by hypothecation of inventories of all types, save and except stores and spares relating to plant and machineries [consumable stores and spares], including goods in transit, bills receivables and book debts [Refer Note-9 and 11]. The value of such current assets is ' 106,727 [as at March 31, 2025: ' 101,139] Million. Quarterly statements, including revised statements, of current assets filed by the Company with bank are in agreement with the books of accounts.
[**] Packing Credit loans in Foreign Currency [PCFC] are payable during next six months. The outstanding amount of loans as at March 31, 2026 is ' 4,743 [as at March 31, 2025 Packing Credit loans in Rupees [PCRE]: ' 8,700] Million.
[***] Loans from others of ' 21,989 [as at March 31, 2025: 21,495] Million are secured by Government Securities.
The interest rate on PCFC loan is SOFR plus a margin. The interest rates on ' loans are in the range of Treasury Bill Plus a margin and overnight interbank rate.
Note: 28-Contingent Liabilities and Commitments [to the extent not provided for]:
' in Million
As at March 31, 2026
As at March 31, 2025
A Contingent Liabilities:
a Claims against the Company not acknowledged as debts
95
116
- Includes in respect of Amalgamated {*} Companies
1
2
b In respect of corporate guarantees given by the Company to wholly owned subsidiary companies
52,613
12,403
c Other money for which the company is contingently liable [**]:
i In respect of the demands raised by the Goods and Service Tax, Central Excise, State Excise, Customs & Service Tax Authority
2,434
721
- Net of advance of
136
63
' in MiLLion
ii In respect of the demands raised by the Ministry of Chemicals & Fertilizers, Govt. of India under Drug Price Control Order, 1979/ 1995 for difference in actual price and price of respective bulk drug allowed while fixing the price of certain formulations and disputed by the Company, which the Company expects to succeed based on the legal advice
79
67
5
iii In respect of Income Tax matters pending before appellate authorities which the Company expects to succeed, based on decisions of Tribunals/ Courts
24
589
19
272
iv In respect of Sales Tax matters pending before appellate authorities/ Court which the Company expects to succeed, based on decisions of Tribunals/ Courts
20
v Letters of Credit for Imports
34
11
vi The Company has imported certain capital equipment at concessional rate of custom duty under “Export Promotion of Capital Goods Scheme” of the Central Government. The Company has undertaken an incremental export obligation to the
- extent of US $ 11 [Previous Year: 8] Million
- equivalent to approx. ' 1,066 [Previous Year: 675] Million
to be fulfilled during a specified period as applicable from the date of imports. The unprovided liability towards custom duty payable thereon in respect of unfulfilled export obligations where the specified period to fulfil the obligation has not expired.
155
111
[*] represents contingent liabilities taken over by the Company under the Scheme of Arrangement and Amalgamation of Cadila Laboratories Limited and erstwhile Cadila Chemicals Limited, Cadila Antibiotics Limited, Cadila Exports Limited and Cadila Veterinary Private Limited with the Company w.e.f. June 1, 1995.
[**] In most of the cases, the relevant authorities have raised demand or disallowed tax claims. The Company has preferred appeals and the outcome are awaited.
B Legal proceedings:
The Company and/or its subsidiaries operating from various jurisdictions are involved in various legal proceedings including product liabilities, employment claims, contracts and other legal and regulatory matters relating to the conduct of its business. Those litigations which involves both the subsidiary and the Company are taken up by the respective subsidiary. The Company and/ or its subsidiaries believe they have meritorious defences to such lawsuits.
The Company does not expect any reimbursements in respect of the above contingent liabilities.
C Commitments:
a Estimated amount of contracts remaining to be executed on capital account and not provided for
5,932
3,623
1,086
734
Note: 29-Proposed Dividend:
The Board of Directors, at its meeting held on May 19, 2026, recommended the final dividend of ' 1/- per equity share of ' 1/- each.
The recommended dividend is subject to the approval of the shareholders at the ensuing Annual General Meeting.
Note: 43-Financial Instruments:
A Fair values hierarchy:
Financial assets and financial Liabilities measured at fair value in the statement of financial position are grouped into three Levels of a fair value hierarchy. The three Levels are defined based on the observability of significant inputs to the measurement, as follows:
Level 1: Quoted prices [unadjusted] in active markets for financial instruments.
Level 2: The fair value of financial instruments that are not traded in an active market is determined using valuation techniques which maximise the use of observable market data relying as little as possible on entity specific estimates.
Level 3: If one or more of the significant inputs is not based on observable market data.
C Fair value of instruments measured at amortised cost:
Financial Assets:
The carrying amounts of trade receivables, Loans and advances to related parties, other financial assets, cash and cash equivalents, investment in preference shares, commercial papers, bonds and debentures are considered to be the approximately equal to the fair values.
Financial Liabilities:
Fair values of borrowings, other financial liabilities and trade payables are considered to be approximately equal to the carrying values.
D Valuation process and technique used to determine fair value:
Specific valuation techniques used to value financial instruments include the use of quoted market prices for similar instruments. The valuation has been derived using the Present Value technique under Income Approach.
Fair values of borrowings, other financial Liabilities and trade payables are considered to be approximately equal to the carrying values.
B Risk Management:
The Company's activities expose it to market risk, liquidity risk and credit risk. This note explains the sources of risk which the entity is exposed to and how the entity manages the risk and the related impact in the standalone financial statements.
The Company's risk management is done in close co-ordination with the board of directors and focuses on actively securing the Company's short, medium and long-term cash flows by minimizing the exposure to volatile financial markets. Long-term financial investments are managed to generate lasting returns. The Company does not actively engage in the trading of financial assets for speculative purposes nor does it write options. The most significant financial risks to which the Company is exposed are described below:
a Credit risk:
Credit risk arises from the possibility that counter party may not be able to settle its obligations as agreed. The Company is exposed to credit risk from investment measured at amortised cost, loans and advances to related parties, trade receivables, bank deposits and other financial assets. The Company periodically assesses the financial reliability of the counter party taking into account the financial condition, current economic trends, analysis of historical bad debts and ageing of accounts receivable. Individual customer limits are set accordingly.
i Investments at Amortised Cost : The Company limits its exposure to credit risk by generally investing in liquid securities and only with counterparties that have a good credit rating. The Company does not expect any significant losses from non-performance by these counterparties and does not have any significant concentration of exposures.
ii Bank deposits : The Company maintains its Cash and cash equivalents and Bank deposits with reputed and highly rated banks. Hence, there is no significant credit risk on such deposits.
iii Loans to related parties : They are given for business purposes. The Company reassesses the recoverability of loans periodically. Interest recoveries from these loans are regular and there is no event of defaults.
iv Trade Receivables: The Company trades with recognized and credit worthy third parties. It is the Company's policy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are monitored on an on-going basis with the result that the Company's exposure to credit losses is not significant.
There are no significant credit risks with related parties of the Company. The Company is exposed to credit risk in the event of non-payment by customers. Credit risk concentration with respect to trade receivables is mitigated by the Company's large customer base. Adequate expected credit losses are recognized as per the assessments. No single third party customer contributes to more than 10% of outstanding accounts receivable [excluding outstanding from subsidiaries] as at March 31, 2026 and March 31, 2025.
The Company has used lifetime expected credit loss [ECL] model for assessing the impairment loss. For the purpose, the Company uses a provision matrix to compute the expected credit loss amount. The provision matrix takes into account external and internal risk factors and historical data of credit losses from various customers. Company has used a practical expedient by computing the expected credit loss allowance for trade receivables based on a provision matrix. The provision matrix considers historical credit loss experience and is adjusted for forward looking information. The maximum exposure to credit risk at the reporting date is the carrying value of trade receivables.
Other than trade receivables, the Company has no significant class of financial assets that is past due but not impaired.
b Liquidity risk:
a Prudent liquidity risk management implies maintaining sufficient cash and marketable securities and the availability of funding through an adequate amount of committed credit facilities to meet obligations when due. Due to the nature of the business, the Company maintains flexibility in funding by maintaining availability under committed facilities.
b Management monitors rolling forecasts of the Company's liquidity position and cash and cash equivalents on the basis of expected cash flows. The Company takes into account the liquidity of the market in which it operates. In addition, the Company's liquidity management policy involves projecting cash flows in major currencies and considering the level of liquid assets necessary to meet these, monitoring balance sheet liquidity ratios against internal and external regulatory requirements and maintaining debt financing plans.
Maturities of financial liabilities:
The tables below analyses the Company's financial liabilities into relevant maturity groupings based on their contractual maturities for all non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows. Balances due within 12 months equal their carrying balances as the impact of discounting is not significant.
The Company has complied with relevant provisions of the Foreign Exchange Management Act, 1999 [42 of 1999] and Companies Act, 2013 and the transactions are not violative of the Prevention of Money-Laundering act, 2002 [15 of 2003].
c The Company has used accounting software for maintaining its books of accounts for the year ended on March 31, 2026 which has a feature of recording audit trail [edit log] facility and the same has been operational throughout the year for all relevant transactions recorded in the software. Audit trail has been preserved by the Company as per the statutory requirements for record retention.
d The Company has not traded or invested in Crypto currency or Virtual currency during the financial year.
e No proceedings have been initiated or pending against the Company for holding any benami property under the Benami Transactions [Prohibition] Act, 1988 (45 of 1988) and the rules made thereunder.
f The Company has not been declared as willful defaulter by any bank or financial Institution or other lender.
g The Company does not have any charges or satisfaction yet to be registered with Registrar of Companies beyond the
statutory period.
h The Company has complied with the number of layers prescribed under clause [87] of section 2 of the Act read with Companies [Restriction on number of Layers] Rules, 2017.
i No Scheme of Arrangements has been approved by the Competent Authority in terms of sections 230 to 237 of the Companies Act, 2013.
j The Company does not have any transaction which is not recorded in the books of accounts that has been surrendered or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 [such as, search or survey or any other relevant provisions of the Income Tax Act, 1961].
Note: 50-Disclosure of transactions with Struck off Companies:
The Company did not have any material transaction with companies struck off under Section 248 of the Companies Act, 2013
or Section 560 of Companies Act, 1956 during the current and previous financial year.
Note: 51:
Figures of previous year have been regrouped/ reclassified to conform to current year's classification.